Document is current
Any future updates will be listed below
-
Authors
Sechaud, Romain
Peters, Thomas
Gu, Helen
Rahmanzadeh, Gholamreza
Sharma, Gopal Krishna
Guichard, Nathalie
Menssen, Hans D.
-
Funding
Funding for this research was provided by:
Novartis
- License Information
-
More Information
Article History
Received: 16 April 2025
Accepted: 14 September 2025
First Online: 23 December 2025
Declarations
:
: The studies were performed in accordance with ethical principles, which have their origin in the Declaration of Helsinki, and are consistent with Good Clinical Practice and applicable regulatory requirements. All participants of the study provided written informed consent according to international standards. The study was registered under EudraCT number: 2017-003540-21, and it obtained a favorable opinion from the IEC. The study participants were informed about the study procedures, risks, and benefits of their participation. Informed consent was documented by the investigator.
: R Sechaud, T Peters, N Guichard, G Rahmanzadeh, and H Menssen are employees of Novartis Pharma AG, Switzerland and may hold shares. H Gu is an employee of Novartis Pharmaceuticals Corporation, USA and may hold shares. G K Sharma is an employee of Novartis Healthcare Pvt. Ltd., India and may hold shares.
